INTERCEPT PHARMACEUTICALS, INC.·4

Jan 3, 4:01 PM ET

Berrey M Michelle 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 3, 2023

Insider Transaction Report

Form 4
Period: 2022-12-31
Berrey M Michelle
President, R&D and CMO
Transactions
  • Tax Payment

    Common Stock

    2022-12-31$12.37/sh765$9,46369,177 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

Documents

1 file
  • 4
    tm231319d1_4.xmlPrimary

    OWNERSHIP DOCUMENT